Luisa Ruiz-Gaton
Overview
Explore the profile of Luisa Ruiz-Gaton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dacoba T, Ruiz-Gaton L, Benito A, Klein M, Dupin D, Luo M, et al.
Drug Deliv Transl Res
. 2020 Feb;
10(3):621-634.
PMID: 32040775
Despite a very active research in the field of nanomedicine, only a few nano-based drug delivery systems have reached the market. The "death valley" between research and commercialization has been...
2.
Ruiz-Gaton L, Espuelas S, Huarte J, Larraneta E, Martin-Arbella N, Irache J
Int J Pharm
. 2019 Sep;
571:118699.
PMID: 31536764
The oral delivery of docetaxel (DTX) is challenging due to a low bioavailability, related to an important pre-systemic metabolism. With the aim of improving the bioavailability of this cytotoxic agent,...
3.
Ruiz-Gaton L, Espuelas S, Larraneta E, Reviakine I, Yate L, Irache J
Eur J Pharm Sci
. 2018 Mar;
118:165-175.
PMID: 29597043
The aim of this work was to investigate the potential of pegylated poly(anhydride) nanoparticles to enhance the oral bioavailability of docetaxel (DTX). Nanoparticles were prepared after the incubation between the...
4.
Calleja P, Huarte J, Agueros M, Ruiz-Gaton L, Espuelas S, Irache J
Ther Deliv
. 2012 Jul;
3(1):43-57.
PMID: 22833932
The oral route is preferred by patients for drug administration due to its convenience, resulting in improved compliance. Unfortunately, for a number of drugs (e.g., anticancer drugs), this route of...